clinical trials

Evolving Treatment of HS

Dr. Sayed presented an overview of treatment options for hidradenitis suppurativa (HS) and reviewed ongoing clinical trials. The landscape of treatment for HS is rapidly changing. Dr. Sayed predicts that many more treatment options will become available in the next 5–10 years. First, Dr. Sayed described current HS treatment options, including adalimumab, infliximab, golimumab, and…

The Translational Educator

Listening to Dr. Victoria Werth lecture in dermatology is like taking a master class —one where you hang onto every word and commit to developing your career with as high a degree of intention as she has.